Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism
Terminated
Avedro, Inc.
Phase 1/Phase 2
2013-08-01
The objectives of this study are to evaluate the safety and efficacy, with regards to
regression of refractive outcome, as measured by manifest refraction spherical equivalent
(MRSE), of two treatment regimens for hyperopic and hyperopic astigmatic subjects: LASIK
followed by cross-linking performed with the KXL System and Photrexa ZD™ (Riboflavin
Ophthalmic Solution), as compared to LASIK alone.
Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism
Terminated
Glaukos Corporation
Phase 1/Phase 2
2013-08-01
The objectives of this study are to evaluate the safety and efficacy, with regards to
regression of refractive outcome, as measured by manifest refraction spherical equivalent
(MRSE), of two treatment regimens for hyperopic and hyperopic astigmatic subjects: LASIK
followed by cross-linking performed with the KXL System and Photrexa ZD™ (Riboflavin
Ophthalmic Solution), as compared to LASIK alone.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
